I was reading the BSH Guidelines for the Estimation of Fetomaternal Haemorrhage, and I had a few questions:
7.2 Slide Preparation
In my current workplace, we do not dilute the sample, and my previous workplace did. I could not see a significant difference on the slide that was made and found them both equally adequate, but I was wondering if other have any input on them
7.3 Controls
We currently prepare the control slide a week in advance and not fix or stain them, until required for batch testing. I have checked all the slides after it had undergone AE test, and all of them had been adequate. I was wondering if there is something which we are overlooking?
These were the only things that were nibbling at the back of my mind after going through the guidelines. If someone could put it to rest, I will be grateful.
Bonus Question
I was wondering if transfusing Rhesus D Negative pregnant women have any implication on the FMH screening/ quantification, and what they would be?
Cheers,
Jermin